-+ 0.00%
-+ 0.00%
-+ 0.00%

On Wing India Deal Change The Bull Case For StandardAero Stock?

Simply Wall St·09/26/2026 10:22:35
Listen to the news
  • StandardAero recently announced a Supplier Service Agreement with GMR Aero Technic to provide on-wing support in India for CFM56-7B and LEAP-1A/1B engines, targeting operators of Airbus A320neo, Boeing 737 MAX and 737NG fleets. These fleets have roughly 1,000 engines in service and 3,200 more on order.
  • The collaboration deepens StandardAero's presence in India by linking its engine maintenance capabilities with GMR Aero Technic's local infrastructure. The partnership is intended to address a large and growing pool of narrowbody powerplants that require recurring maintenance, repair and overhaul work.
  • We will now look at how StandardAero's new on-wing support partnership in India could reshape the broader investment narrative.

Scan how StandardAero’s India move compares with other aviation players positioning for narrowbody engine demand by reviewing the hand-picked list of solid balance sheet and fundamentals (24 results).

StandardAero Investment Narrative Recap

For you to back StandardAero, you need to believe its engine maintenance and repair network can keep absorbing more LEAP and CFM56 work while turning that volume into healthier margins over time. The India on wing agreement ties the business more tightly to a large pool of Airbus A320neo and Boeing 737 MAX engines, which supports that utilization story rather than changing it.

The near term swing factor still sits in execution on LEAP and CFM56 programs that are currently at zero margin and expected to improve as learning curves mature. The main risk remains supply chain pressure and parts availability, which could limit engine turns and delay any margin inflection, even with new agreements in place.

The GMR Aero Technic deal is the announcement that really matters here. It plugs StandardAero into roughly 1,000 engines already flying in India and thousands more on order, which directly links to the core LEAP and CFM56 catalyst that analysts focus on for future revenue and earnings growth.

Operationally, this raises the stakes on execution. More access to engines only helps if parts constraints, labor, and shop capacity keep pace, and if currently dilutive programs move toward positive contribution as expected. Any stumble in that transition, or weaker free cash flow given debt is not well covered by operating cash flow, would quickly test the bullish thesis.

StandardAero’s current analyst story points to revenues of US$7.3b and earnings of US$549.2m by 2028. These figures are built on an assumed 7.4% yearly revenue growth rate and an earnings increase of about US$364.5m from earnings today of US$184.7m.

Uncover why StandardAero's fair value indicates a 56% potential upside to its current price, which could narrow quickly as confidence in StandardAero’s execution builds.

NYSE:SARO 1-Year Stock Price Chart
NYSE:SARO 1-Year Stock Price Chart

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community cluster in a tight US$33.70 to US$37.93 band, so retail views on StandardAero currently sit in a fairly narrow range. Those opinions pre date the India on wing deal and MRO Asia visibility, so you may want to weigh fresh contract risk and execution upside before leaning on them.

Explore 3 other StandardAero fair value estimates, including one that suggests it could be worth just $33.70!

The Verdict Is Yours

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

Looking For More Investment Ideas Beyond StandardAero?

Once you have a handle on the StandardAero story, it can help to compare it with other opportunities that share similar strengths or offer very different types of potential. The Simply Wall St Screener lets you scan the market quickly using clear, fundamentals based filters.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.